Edition:
United States

Arbutus Biopharma Corp (ABUS.OQ)

ABUS.OQ on NASDAQ Stock Exchange Global Select Market

4.34USD
19 Oct 2018
Change (% chg)

$-0.10 (-2.25%)
Prev Close
$4.44
Open
$4.39
Day's High
$4.54
Day's Low
$4.34
Volume
77,234
Avg. Vol
162,146
52-wk High
$12.50
52-wk Low
$4.02

Chart for

About

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple... (more)
No analyst recommendations are available for .

Overall

Beta: 0.72
Market Cap(Mil.): $652.85
Shares Outstanding(Mil.): 55.40
Dividend: --
Yield (%): --

Financials

  ABUS.OQ Industry Sector
P/E (TTM): -- 29.75 32.14
EPS (TTM): -2.22 -- --
ROI: -51.57 13.18 12.83
ROE: -55.72 15.14 14.95

Earnings vs. Estimates